share_log

Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference

Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference

Grey Wolf Animal Health 將在 2023 年布魯姆·伯頓公司上發表演講醫療保健投資者會議
newsfile ·  2023/04/13 16:35

Toronto, Ontario--(Newsfile Corp. - April 13, 2023) - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the 2023 Bloom Burton & Co. Healthcare Investor Conference on Tuesday April 25, 2023 at 2:30pm ET at the Metro Toronto Convention Centre in Toronto.

安大略省多倫多--(Newsfile Corp.——2023年4月13日)——加拿大多元化動物健康公司灰狼動物健康公司(TSXV:WOLF)(“灰狼” 或 “公司”)今天宣佈,首席執行官安吉拉·切切託計劃在2023年Bloom Burton & Co.上發佈公司最新情況。醫療保健投資者會議將於美國東部時間2023年4月25日星期二下午 2:30 在多倫多大都會會議中心舉行。

Grey Wolf management will also be available for one-on-one meetings during both days of the conference to be held on April 25-26, 2023. Investors interested in meeting with Grey Wolf during the conference should contact the conference coordinator or email investors@greywolfah.com.

在將於2023年4月25日至26日舉行的兩天會議期間,Grey Wolf管理層也將可以進行一對一的會議。有興趣在會議期間與Grey Wolf會面的投資者應聯繫會議協調員或發送電子郵件至 investors@greywolfah.com。

About Grey Wolf Animal Health Corp.‎

關於灰狼動物健康公司

Grey Wolf Animal Health Corp., headquartered in Toronto, Canada, is a diversified animal health ‎company founded by a veterinarian to bring to market a broad portfolio of products that meets the ‎unmet needs of veterinarians, clinics and pets. The Company's strategy is to in-license, acquire or develop innovative prescription and non-prescription products for commercialization in the veterinarian channel ‎in Canada. For additional information, please visit: .‎

Grey Wolf Animal Health Corp. 總部位於加拿大多倫多,是一家由獸醫創立的多元化動物健康公司,旨在將廣泛的產品組合推向市場,以滿足獸醫、診所和寵物未得到滿足的需求。該公司的戰略是許可、收購或開發創新的處方和非處方產品,以便在加拿大獸醫渠道進行商業化。欲瞭解更多信息,請訪問:。

For further information, please contact:‎

欲瞭解更多信息,請聯繫:

Angela Cechetto
Chief Executive Officer
E-mail: investors@greywolfah.com

安吉拉·切切託
首席執行官
電子郵件:investors@greywolfah.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Forward-Looking Statements

前瞻性陳述

This news release includes certain statements that may be deemed "forward-looking statements." All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," and similar expressions, or that events or conditions "will," "would," "may," "could," or "should" occur. Forward-looking information in this news release includes statements related to the Company's attendance at the 2023 Bloom Burton & Co. Healthcare Investor Conference. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

本新聞稿包括某些可能被視爲 “前瞻性陳述” 的陳述。除歷史事實陳述外,本新新聞稿中涉及公司預計將發生的事件或事態發展的所有陳述均爲前瞻性陳述。前瞻性陳述不是歷史事實,通常但並非總是以 “期望”、“計劃”、“預期”、“相信”、“打算”、“估計”、“項目”、“潛力” 和類似表達方式來識別,或者事件或條件 “將”、“將”、“可能” 或 “應該” 發生。本新聞稿中的前瞻性信息包括與公司出席2023年Bloom Burton & Co.有關的聲明。醫療保健投資者會議。前瞻性陳述基於公司管理層在陳述發表之日的信念、估計和觀點。除非適用的證券法有要求,否則如果管理層的信念、估計或觀點或其他因素髮生變化,公司沒有義務更新這些前瞻性陳述。

To view the source version of this press release, please visit

要查看本新聞稿的源版本,請訪問

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論